Revelation Biosciences stock price

레벌레이션 바이오사이언시스NASDAQ:REVB · Nasdaq · Healthcare · sector #17
$0.7522-3.20%
2026-10-06 close
Loading chart…

Today's signals · No active technical signal.

Signal details →

Revelation Biosciences last closed at $0.7522 (-3.20%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 657 of 740 stocks in Healthcare.

About this company

Revelation Biosciences last closed at $0.7522 (-3.20%) on 2026-10-06. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall D · 657/740

Valuation grade C+

Details →

Related stocks

  • RocheCompetitor

    Revelation Biosciences와 같은 면역·염증/진단 계열 바이오 영역에서 비교되는 글로벌 대형 제약·진단사

  • MerckCompetitor

    면역·염증 및 감염질환 치료제 개발 경쟁에서 비교 대상이 되는 대형 제약사

  • 면역·염증 및 제약 파이프라인 측면에서 경쟁하는 글로벌 헬스케어 대기업

Details →
About Revelation Biosciences
What technical signals does Revelation Biosciences (REVB) have?
Revelation Biosciences current technical signals: no active technical signal.
Is Revelation Biosciences a cup-and-handle pattern?
No. Revelation Biosciences has no valid Cup signal right now.
What published figures are available for Revelation Biosciences?
Market cap: $1.11M. Trailing 12 months PER: -0.3×. Latest quarter PBR: 0.29×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Revelation Biosciences, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Revelation Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy